Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Diabetes

  Free Subscription


08.07.2019

1 Am J Clin Nutr
1 Am J Epidemiol
2 Am J Kidney Dis
1 Am J Ophthalmol
2 Ann Intern Med
3 BMJ
11 Diabet Med
1 Diabetes
4 Diabetes Care
8 Diabetes Obes Metab
4 Diabetologia
1 J Autoimmun
3 J Biol Chem
2 J Clin Endocrinol Metab
2 J Clin Invest
6 J Diabetes Complications
2 J Nutr
1 Kidney Int
4 Lancet Diabetes Endocrinol
1 Med Care
1 Metabolism
1 Nat Genet
5 Pediatr Diabetes
3 PLoS One
1 Transplant Proc


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Nutr

  1. CHEN Y, Liu H, Wang L, Zhou T, et al
    Lifestyle intervention modifies the effect of the MC4R genotype on changes in insulin resistance among women with prior gestational diabetes: Tianjin Gestational Diabetes Mellitus Prevention Program.
    Am J Clin Nutr. 2019 Jul 4. pii: 5528130. doi: 10.1093.
    PubMed     Text format     Abstract available


    Am J Epidemiol

  2. DANKNER R, Agay N, Olmer L, Murad H, et al
    Metformin Treatment and Cancer Risk: Cox Regression Analysis with Time-Dependent Covariates of 320,000 Individuals with Incident Diabetes Mellitus.
    Am J Epidemiol. 2019 Jul 3. pii: 5527968. doi: 10.1093.
    PubMed     Text format     Abstract available


    Am J Kidney Dis

  3. COOPER ME, Inzucchi SE, Zinman B, Hantel S, et al
    Glucose Control and the Effect of Empagliflozin on Kidney Outcomes in Type 2 Diabetes: An Analysis From the EMPA-REG OUTCOME Trial.
    Am J Kidney Dis. 2019 Jun 26. pii: S0272-6386(19)30735.
    PubMed     Text format    

  4. BAKRIS GL
    Major Advancements in Slowing Diabetic Kidney Disease Progression: Focus on SGLT2 Inhibitors.
    Am J Kidney Dis. 2019 Jun 28. pii: S0272-6386(19)30776.
    PubMed     Text format    


    Am J Ophthalmol

  5. YORGUN MA
    Effects of Crocin on Diabetic Maculopathy: A Placebo-Controlled Randomized Clinical Trial.
    Am J Ophthalmol. 2019 Jun 27. pii: S0002-9394(19)30129.
    PubMed     Text format    


    Ann Intern Med

  6. KE C, Shah BR, Stukel TA, Chan JCN, et al
    Excess Burden of Mental Illness and Hospitalization in Young-Onset Type 2 Diabetes.
    Ann Intern Med. 2019;171:78-79.
    PubMed     Text format    

  7. FINUCANE TE
    Excess Burden of Mental Illness and Hospitalization in Young-Onset Type 2 Diabetes.
    Ann Intern Med. 2019;171:78.
    PubMed     Text format    


    BMJ

  8. SHEIKH Z, Akali A
    An unstable lump in the groin.
    BMJ. 2019;365:l2214.
    PubMed     Text format    

  9. NEUENSCHWANDER M, Ballon A, Weber KS, Norat T, et al
    Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies.
    BMJ. 2019;366:l2368.
    PubMed     Text format     Abstract available

  10. JIAO J, Liu G, Shin HJ, Hu FB, et al
    Dietary fats and mortality among patients with type 2 diabetes: analysis in two population based cohort studies.
    BMJ. 2019;366:l4009.
    PubMed     Text format     Abstract available


    Diabet Med

  11. AKIBOYE F, Adderley NJ, Martin J, Gokhale K, et al
    Impact of the Diabetes Inpatient Care and Education (DICE) project on length of stay and mortality.
    Diabet Med. 2019 Jul 2. doi: 10.1111/dme.14062.
    PubMed     Text format     Abstract available

  12. DUCOS C, Rigalleau V, Foussard N, Cambos S, et al
    Why might pumps fail in pregnant women with Type 1 diabetes?
    Diabet Med. 2019 Jul 2. doi: 10.1111/dme.14063.
    PubMed     Text format     Abstract available

  13. BURCKHARDT MA, Fried L, Bebbington K, Hancock M, et al
    Use of remote monitoring with continuous glucose monitoring in young children with Type 1 diabetes: the parents' perspective.
    Diabet Med. 2019 Jun 30. doi: 10.1111/dme.14061.
    PubMed     Text format     Abstract available

  14. NARENDRAN P, Greenfield S, Troughton J, Doherty Y, et al
    Development of a group structured education programme to support safe exercise in people with Type 1 diabetes: the EXTOD education programme.
    Diabet Med. 2019 Jul 2. doi: 10.1111/dme.14064.
    PubMed     Text format     Abstract available

  15. KIM HL, Kim MA, Park KT, Choi DJ, et al
    Gender difference in the impact of coexisting diabetes mellitus on long-term clinical outcome in people with heart failure: a report from the Korean Heart Failure Registry.
    Diabet Med. 2019 Jun 29. doi: 10.1111/dme.14059.
    PubMed     Text format     Abstract available

  16. BAIN SC, Bakhai A, Evans M, Green A, et al
    Pharmacological treatment for Type 2 diabetes integrating findings from cardiovascular outcome trials: an expert consensus in the UK.
    Diabet Med. 2019 Jun 29. doi: 10.1111/dme.14058.
    PubMed     Text format     Abstract available

  17. REHACKOVA L, Araujo-Soares V, Steven S, Adamson AJ, et al
    Behaviour change during dietary Type 2 diabetes remission: a longitudinal qualitative evaluation of an intervention using a very low energy diet.
    Diabet Med. 2019 Jul 3. doi: 10.1111/dme.14066.
    PubMed     Text format     Abstract available

  18. HENDRIECKX C, Ivory N, Singh H, Frier BM, et al
    Impact of severe hypoglycaemia on psychological outcomes in adults with Type 2 diabetes: a systematic review.
    Diabet Med. 2019 Jul 4. doi: 10.1111/dme.14067.
    PubMed     Text format     Abstract available

  19. SATTAR N
    Diabetes management gains: teaching old dogs new tricks.
    Diabet Med. 2019 Jul 4. doi: 10.1111/dme.14068.
    PubMed     Text format     Abstract available

  20. BETHIN KE, Kanapka LG, Laffel LM, Majidi S, et al
    Autism spectrum disorder in children with Type 1 diabetes.
    Diabet Med. 2019 Jul 4. doi: 10.1111/dme.14069.
    PubMed     Text format     Abstract available

  21. YAGHOOTKAR H, Abbasi F, Ghaemi N, Rabbani A, et al
    Type 1 diabetes genetic risk score discriminates between monogenic and Type 1 diabetes in children diagnosed at the age of <5 years in the Iranian population.
    Diabet Med. 2019 Jul 5. doi: 10.1111/dme.14071.
    PubMed     Text format     Abstract available


    Diabetes

  22. ROBERTS GP, Larraufie P, Richards P, Kay RG, et al
    Comparison of Human and Murine Enteroendocrine Cells by Transcriptomic and Peptidomic Profiling.
    Diabetes. 2019;68:1062-1072.
    PubMed     Text format     Abstract available


    Diabetes Care

  23. GUO J, Brooks MM, Muldoon MF, Naimi AI, et al
    Optimal Blood Pressure Thresholds for Minimal Coronary Artery Disease Risk in Type 1 Diabetes.
    Diabetes Care. 2019 Jun 27. pii: dc19-0480. doi: 10.2337/dc19-0480.
    PubMed     Text format     Abstract available

  24. PILEMANN-LYBERG S, Rasmussen DGK, Hansen TW, Tofte N, et al
    Markers of Collagen Formation and Degradation Reflect Renal Function and Predict Adverse Outcomes in Patients With Type 1 Diabetes.
    Diabetes Care. 2019 Jul 1. pii: dc18-2599. doi: 10.2337/dc18-2599.
    PubMed     Text format     Abstract available

  25. LIAO WC, Huang BS, Yu YH, Yang HH, et al
    Galectin-3 and S100A9: Novel Diabetogenic Factors Mediating Pancreatic Cancer-Associated Diabetes.
    Diabetes Care. 2019 Jul 1. pii: dc19-0217. doi: 10.2337/dc19-0217.
    PubMed     Text format     Abstract available

  26. RIDDLE MC, Gerstein HC
    The Cardiovascular Legacy of Good Glycemic Control: Clues About Mediators From the DCCT/EDIC Study.
    Diabetes Care. 2019;42:1159-1161.
    PubMed     Text format    


    Diabetes Obes Metab

  27. DEEROCHANAWONG C, Pheng CS, Matawaran BJ, Sheu WH, et al
    Use of SGLT-2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: an Asian perspective and expert recommendations.
    Diabetes Obes Metab. 2019 Jul 2. doi: 10.1111/dom.13819.
    PubMed     Text format     Abstract available

  28. BAKER C, Wason S, Banks P, Sawhney S, et al
    Dose-Dependent Glycometabolic Effects of Sotagliflozin on Type 1 Diabetes Over 12 Weeks: the inTandem4 Trial.
    Diabetes Obes Metab. 2019 Jul 2. doi: 10.1111/dom.13825.
    PubMed     Text format     Abstract available

  29. HOLLANDER PA, Kiljanski J, Spaepen E, Harris CJ, et al
    The Risk of Clinically Relevant Hypoglycaemia in Patients with Type 2 Diabetes Self-titrating Insulin Glargine U-100.
    Diabetes Obes Metab. 2019 Jul 2. doi: 10.1111/dom.13822.
    PubMed     Text format     Abstract available

  30. KENG MJ, Tsiachristas A, Leal J, Gray A, et al
    Impact of achieving primary care targets in Type 2 diabetes on health outcomes and healthcare costs.
    Diabetes Obes Metab. 2019 Jul 2. doi: 10.1111/dom.13821.
    PubMed     Text format     Abstract available

  31. MULDER S, Heerspink HJL, Darshi M, Kim JJ, et al
    The effects of dapagliflozin on urinary metabolites in patients with type 2 diabetes.
    Diabetes Obes Metab. 2019 Jul 2. doi: 10.1111/dom.13823.
    PubMed     Text format     Abstract available

  32. LEGA IC, Bronskill SE, Campitelli MA, Guan J, et al
    Sodium glucose cotransporter 2 inhibitors and risk of genital mycotic and urinary tract infections: a population-based study of older women and men with diabetes.
    Diabetes Obes Metab. 2019 Jul 2. doi: 10.1111/dom.13820.
    PubMed     Text format     Abstract available

  33. BAILEY TS, Wu J, Zhou FL, Gupta MTech RA, et al
    Switching to insulin glargine 300 units/mL in real-world older type 2 diabetes patients (DELIVER 3).
    Diabetes Obes Metab. 2019 Jul 2. doi: 10.1111/dom.13818.
    PubMed     Text format     Abstract available

  34. PRATLEY RE, Kang J, Trautmann ME, Hompesch M, et al
    Body weight management and safety with efpeglenatide in adults without diabetes: a phase II randomized study.
    Diabetes Obes Metab. 2019 Jul 2. doi: 10.1111/dom.13824.
    PubMed     Text format     Abstract available


    Diabetologia

  35. NATHAN DM, Bennett PH, Crandall JP, Edelstein SL, et al
    Does diabetes prevention translate into reduced long-term vascular complications of diabetes?
    Diabetologia. 2019 Jul 4. pii: 10.1007/s00125-019-4928.
    PubMed     Text format     Abstract available

  36. EKMAN I, Ihantola EL, Viisanen T, Rao DA, et al
    Circulating CXCR5(-)PD-1(hi) peripheral T helper cells are associated with progression to type 1 diabetes.
    Diabetologia. 2019 Jul 3. pii: 10.1007/s00125-019-4936.
    PubMed     Text format     Abstract available

  37. ECKEL J
    Myokines in metabolic homeostasis and diabetes.
    Diabetologia. 2019 Jul 1. pii: 10.1007/s00125-019-4927.
    PubMed     Text format     Abstract available

  38. BOGDANET D, Reddin C, Macken E, Griffin TP, et al
    Follow-up at 1 year and beyond of women with gestational diabetes treated with insulin and/or oral glucose-lowering agents: a core outcome set using a Delphi survey.
    Diabetologia. 2019 Jul 4. pii: 10.1007/s00125-019-4935.
    PubMed     Text format     Abstract available


    J Autoimmun

  39. ZENTSOVA I, Parackova Z, Kayserova J, Palova-Jelinkova L, et al
    Monocytes contribute to DNA sensing through the TBK1 signaling pathway in type 1 diabetes patients.
    J Autoimmun. 2019 Jun 27. pii: S0896-8411(19)30191.
    PubMed     Text format     Abstract available


    J Biol Chem

  40. JIA Y, Reddy MA, Das S, Oh HJ, et al
    Dysregulation of histone H3 lysine 27 trimethylation in transforming growth factor-beta1 induced gene expression in mesangial cells and diabetic kidney.
    J Biol Chem. 2019 Jul 2. pii: RA119.007575. doi: 10.1074/jbc.RA119.007575.
    PubMed     Text format     Abstract available

  41. SUN L, Pan X, Wada J, Haas CS, et al
    Withdrawal: Isolation and functional analysis of mouse UbA52 gene and its relevance to diabetic nephropathy.
    J Biol Chem. 2019;294:10382.
    PubMed     Text format    

  42. SUN L, Dutta RK, Xie P, Kanwar YS, et al
    Withdrawal: myo-Inositol oxygenase overexpression accentuates generation of reactive oxygen species and exacerbates cellular injury following high glucose ambience: A new mechanism relevant to the pathogenesis of diabetic nephropathy.
    J Biol Chem. 2019;294:10380.
    PubMed     Text format    


    J Clin Endocrinol Metab

  43. TSANG VHM, McGrath RT, Clifton-Bligh RJ, Scolyer RA, et al
    Checkpoint inhibitor associated autoimmune diabetes (CIADM) is distinct from type 1 diabetes.
    J Clin Endocrinol Metab. 2019 Jul 2. pii: 5526756. doi: 10.1210/jc.2019-00423.
    PubMed     Text format     Abstract available

  44. CHEN HM, Yang YH, Chen KJ, Lee Y, et al
    Antidepressants reduced risk of mortality in patients with diabetes mellitus: a population-based cohort study in Taiwan.
    J Clin Endocrinol Metab. 2019 Jul 2. pii: 5526757. doi: 10.1210/jc.2018-02362.
    PubMed     Text format     Abstract available


    J Clin Invest

  45. JAAFAR R, Tran S, Shah A, Sun G, et al
    mTORC1 to AMPK switching underlies beta-cell metabolic plasticity during maturation and diabetes.
    J Clin Invest. 2019;130.
    PubMed     Text format     Abstract available

  46. YU MG, Keenan HA, Shah HS, Frodsham SG, et al
    Residual beta cell function and monogenic variants in long-duration type 1 diabetes patients.
    J Clin Invest. 2019;130.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  47. PIOTROWICZ AK, McGill MJ, Overland J, Molyneaux L, et al
    An on-line support tool to reduce exercise-related hypoglycaemia and improve confidence to exercise in type 1 diabetes.
    J Diabetes Complications. 2019 May 28. pii: S1056-8727(19)30107.
    PubMed     Text format     Abstract available

  48. BAIER JM, Funck KL, Petersen L, Vernstrom L, et al
    Retinal vessel reactivity is not attenuated in patients with type 2 diabetes compared with matched controls and is associated with peripheral endothelial function in controls.
    J Diabetes Complications. 2019 Jun 3. pii: S1056-8727(19)30235.
    PubMed     Text format     Abstract available

  49. ZHANG X, Pek SLT, Tavintharan S, Sum CF, et al
    Leucine-rich alpha-2-glycoprotein predicts proliferative diabetic retinopathy in type 2 diabetes.
    J Diabetes Complications. 2019 May 31. pii: S1056-8727(18)30956.
    PubMed     Text format     Abstract available

  50. ZHANG C, Zhong Y, Tian H
    Increased cardio-ankle vascular index is independently associated with chronic kidney disease: A cross-sectional study in Chinese patients with type 2 diabetes mellitus.
    J Diabetes Complications. 2019 May 17. pii: S1056-8727(19)30137.
    PubMed     Text format     Abstract available

  51. WIROMRAT P, Bjornstad P, Roncal C, Pyle L, et al
    Serum uromodulin is associated with urinary albumin excretion in adolescents with type 1 diabetes.
    J Diabetes Complications. 2019 Jun 3. pii: S1056-8727(19)30197.
    PubMed     Text format     Abstract available

  52. BHATTARAI S, Godsland IF, Misra S, Johnston DG, et al
    Metabolic health and vascular complications in type 1 diabetes.
    J Diabetes Complications. 2019 Jun 7. pii: S1056-8727(18)31283.
    PubMed     Text format     Abstract available


    J Nutr

  53. SAANDE CJ, Webb JL, Curry PE, Rowling MJ, et al
    Dietary Whole Egg Reduces Body Weight Gain in a Dose-Dependent Manner in Zucker Diabetic Fatty Rats.
    J Nutr. 2019 Jun 29. pii: 5525195. doi: 10.1093.
    PubMed     Text format     Abstract available

  54. ZABETIAN-TARGHI F, Srikanth VK, Smith KJ, Oddy WH, et al
    Dietary Patterns Are Not Associated with Brain Atrophy or Cerebral Small Vessel Disease in Older Adults with and without Type 2 Diabetes.
    J Nutr. 2019 Jun 29. pii: 5525193. doi: 10.1093.
    PubMed     Text format     Abstract available


    Kidney Int

  55. BARBOUR S, Djurdjev O, Gill JS, Dong JJ, et al
    A propensity score matched analysis shows no adverse effect of early steroid withdrawal in non-diabetic kidney transplant recipients with and without glomerulonephritis.
    Kidney Int. 2019 Apr 1. pii: S0085-2538(19)30388.
    PubMed     Text format     Abstract available


    Lancet Diabetes Endocrinol


  56. Correction to Lancet Diabetes Endocrinol 2019; 7: 356-67.
    Lancet Diabetes Endocrinol. 2019 Jul 1. pii: S2213-8587(19)30220.
    PubMed     Text format    

  57. RAAL FJ, Mohamed F
    More aggressive lipid lowering in people with diabetes?
    Lancet Diabetes Endocrinol. 2019 Jul 1. pii: S2213-8587(19)30190.
    PubMed     Text format    

  58. MONTERO D, Diaz-Canestro C, Oberholzer L, Lundby C, et al
    The role of blood volume in cardiac dysfunction and reduced exercise tolerance in patients with diabetes.
    Lancet Diabetes Endocrinol. 2019 Jun 26. pii: S2213-8587(19)30119.
    PubMed     Text format     Abstract available

  59. RAY KK, Colhoun HM, Szarek M, Baccara-Dinet M, et al
    Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.
    Lancet Diabetes Endocrinol. 2019 Jul 1. pii: S2213-8587(19)30158.
    PubMed     Text format     Abstract available


    Med Care

  60. BASU S, Narayanaswamy R
    A Prediction Model for Uncontrolled Type 2 Diabetes Mellitus Incorporating Area-level Social Determinants of Health.
    Med Care. 2019 Jul 1. doi: 10.1097/MLR.0000000000001147.
    PubMed     Text format     Abstract available


    Metabolism

  61. ALEXOPOULOS AS, Buse JB
    Initial injectable therapy in type 2 diabetes: key considerations when choosing between glucagon-like peptide 1 receptor agonists and insulin.
    Metabolism. 2019 Jun 27. pii: S0026-0495(19)30127.
    PubMed     Text format     Abstract available


    Nat Genet

  62. MIGUEL-ESCALADA I, Bonas-Guarch S, Cebola I, Ponsa-Cobas J, et al
    Human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes.
    Nat Genet. 2019;51:1137-1148.
    PubMed     Text format     Abstract available


    Pediatr Diabetes

  63. POWELL J, Isom S, Divers J, Bellatorre A, et al
    Increasing Burden of Type 2 Diabetes in Navajo Youth: The SEARCH for Diabetes in Youth Study.
    Pediatr Diabetes. 2019 Jul 1. doi: 10.1111/pedi.12885.
    PubMed     Text format     Abstract available

  64. MARKER AM, Patton SR, McDonough RJ, Feingold H, et al
    Implementing clinic-wide depression screening for pediatric diabetes: An initiative to improve healthcare processes.
    Pediatr Diabetes. 2019 Jul 2. doi: 10.1111/pedi.12886.
    PubMed     Text format     Abstract available

  65. BRORSSON AL, Leksell J, Franko MA, Olinder AL, et al
    A person-centered education for adolescents with type 1 diabetes - A randomized controlled trial.
    Pediatr Diabetes. 2019 Jul 3. doi: 10.1111/pedi.12888.
    PubMed     Text format     Abstract available

  66. WAGNER JA, Petry NM, Weyman K, Tichy E, et al
    Glucose management for rewards: A randomized trial to improve glucose monitoring and associated self-management behaviors in adolescents with type 1 diabetes.
    Pediatr Diabetes. 2019 Jul 4. doi: 10.1111/pedi.12889.
    PubMed     Text format     Abstract available

  67. IBANEZ-BRURON MC, Solebo AL, Cumberland PM, Rahi JS, et al
    Vulnerabilities in diabetic eye screening for children and young people in England.
    Pediatr Diabetes. 2019 Jul 3. doi: 10.1111/pedi.12887.
    PubMed     Text format     Abstract available


    PLoS One

  68. BARR MM, Aslibekyan S, Ashraf AP
    Glycemic control and lipid outcomes in children and adolescents with type 2 diabetes.
    PLoS One. 2019;14:e0219144.
    PubMed     Text format     Abstract available

  69. SEGAFREDO G, Kapur A, Robbiati C, Joseph N, et al
    Integrating TB and non-communicable diseases services: Pilot experience of screening for diabetes and hypertension in patients with Tuberculosis in Luanda, Angola.
    PLoS One. 2019;14:e0218052.
    PubMed     Text format     Abstract available

  70. SHAVIT-STEIN E, Aronovich R, Sylantiev C, Gofrit SG, et al
    The role of thrombin in the pathogenesis of diabetic neuropathy.
    PLoS One. 2019;14:e0219453.
    PubMed     Text format     Abstract available


    Transplant Proc

  71. ERTURK T, Berber I, Cakir U
    Effect of Obesity on Clinical Outcomes of Kidney Transplant Patients.
    Transplant Proc. 2019;51:1093-1095.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: